Mark Rosenthal (M A Rosenthal)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Venues

ESMO open

Cost effectiveness and resource allocation : C/E

BMJ open

AJNR. American journal of neuroradiology

Peter MacCallum Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peter MacCallum Cancer Institute Aug 01 2016

Australia

Medical Oncologist :: Medical Oncology

Publications

Eng-Siew Koh, Hui Kong Gan, Clare Senko, Roslyn Jane Francis, Martin Andrew Ebert, Sze Ting Lee, Eddie Lau, Mustafa Khasraw, Anna K Nowak, Dale L Bailey, Bradford A Moffat, Gregory Fitt, Rodney John Hicks, D Borden Lacy, Roel G W Verhaak, Kyle M Walsh, Elizabeth H Barnes, Richard De Abreu Lourenço, Mark Rosenthal, Lucas Adda, Farshad Foroudi, Arian Lasocki, Alisha Moore, Paul A Thomas, Paul Roach, Michael F Back, Robyn Leonard, Andrew Mark Scott
[ 18 F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. BMJ open 13 (8) (2023)
Piers Gillett, Robert K Mahar, Nancy R Tran, Mark Rosenthal, Maarten J IJzerman
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value. Cost effectiveness and resource allocation : C/E 21 (1) (2023)
Mark Rosenthal, Paul M Clement, Mario Campone, Miguel J Gil-Gil, John DeGroot, Olivier Chinot, Ahmed Idbaih, Hui Gan, Jeffrey Raizer, Patrick Yung Wen, Estela Pineda, Valerie Donnet, David Mills, Mona El-Hashimy, Warren Mason
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study. ESMO open 5 (4) (2021)
Patrick Yung Wen, Jordi A Rodon, Warren Mason, Joseph T Beck, John DeGroot, Valerie Donnet, David Mills, Mona El-Hashimy, Mark Rosenthal
Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. ESMO open 5 (4) (2021)
Arian Lasocki, Mark Rosenthal, S J Roberts-Thomson, Andrew Neal, Katharine J Drummond
Neuro-Oncology and Radiogenomics: Time to Integrate? AJNR. American journal of neuroradiology 41 (11) (2020)

Mark Rosenthal.css-eqlu8i{font-size:small;padding-left:4px;} (M A Rosenthal)

Publication Activity (10 Years)

Top Topics

Top Venues

Mark Rosenthal (M A Rosenthal)